Microdose Psychedelic Insights, the premier global guide to the business of psychedelics, hosted a successful Psychedelic Capital Conference in an entirely virtual format, Tuesday, July 26, 2022.
The July edition of the Microdose event introduced the investors and attendees to top investors, entrepreneurs, psychedelic researchers, latest IPO and health leaders, sharing valuable insights into the psychedelic sector. Part of a bimonthly investor conference series that dives deep into psychedelic medicine investment, this event was focused on driving the psychedelic industry to the forefront of modern medicine.
CEOs, capital advisors, analysts, and investment luminaries from across the global spectrum, shared valuable content about the growing psychedelic space, provided important report analysis, and discussed the latest news and market strategies. The July PsyCap featured segments on the introduction and potential of virtual reality (“VR”) to deal with mental health treatments in the psychedelic space.
Capitalists, investors, financial institute heads, and other attendees, learned the latest financial updates about the market from an expert perspective, with a multi-disciplinary panel of experts including Jayashree Mitra, Nanea Ree Lyle Maxson, Agnieszka Sekula, Patrick Trucchio, and Maria Velkova, discussing how transformative technology is shaping the future of the industry and its impact on financial markets.
“The psychedelics industry is poised to provide much-needed therapies to address various medical complications, including the surging mental health crisis. By bringing valuable insights directly to the people, we aim to democratize access to critical information and help average investors navigate this dynamic industry,” said Patrick Moher, President of Microdose Psychedelic Insights.
Doing Good is a new segment that all Psychedelic Capital Conferences are featuring this year, as non-profits leveraged this global platform to showcase their important work. The July edition of PsyCap Doing Good presentation was hosted by Blessings Of The Forest’s Medical Reciprocity Manager, Dr. Kirran Ahmad. Blessing Of The Forest is a non-profit organization dedicated to advocating and preserving information about the medicinal plants and indigenous traditions of the Gabonese forest people.
Along with several corporate presentations, the title sponsor for the July PsyCap event hosted their segment titled: Risk Management in Emerging Markets – Psychedelic Medicine and Therapies.
Representatives of NFP, an international insurance broker and consulting company, offered panelists Scott Foster, Morgan Frick, and Adam Wilkins, who discussed how NFP came to this field. With NFP’s experience with other recent emerging markets, cannabis, in particular, it’s especially able to assist companies in this space.
Mindstate Design Labs CEO Dillan DiNardo offered an understanding of the company’s mission to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal mental health disorders.
In addition, Microdose has created a public-facing Deal Board, powered by Mission Club, presenting an investment opportunity with Maya Health‘s CEO & Founder David Champion. Maya Health focuses on building a future where people have easy and safe access to psychedelic medicine.
To learn more, please visit https://ibn.fm/dtpCF.
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php